title: Micafungin therapy in a critically ill, morbidly obese patient.
authors.forename: Amanda
authors.initials: A
authors.lastname: Zomp
authors.forename: P Brandon
authors.initials: PB
authors.lastname: Bookstaver
authors.forename: Yasir
authors.initials: Y
authors.lastname: Ahmed
authors.forename: J Elliot
authors.initials: JE
authors.lastname: Turner
authors.forename: Christie
authors.initials: C
authors.lastname: King
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D041221:Candida glabrata / Q000187:drug effects*; D002177:Candidiasis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D016638:Critical Illness; D054714:Echinocandins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D055666:Lipopeptides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000077551:Micafungin; D009767:Obesity, Morbid / Q000150:complications
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D000077551:Micafungin